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Abstract  14 
The use of a proteomic approach to investigate changes in the milk proteome is 15 
growing and has parralleled the increasing technological developments in proteomics 16 
moving from early investigation using a gel based two dimensional separation 17 
approach to more quantitative method of current focus applying chromatography and 18 
mass spectrometry.  Proteomic approaches to investigate lactational performance 19 
have made substantial findings especially in the alterations in lactation during 20 
mastitis.  An experimental model of Streptococcus uberis infection of the mammary 21 
gland has been used as a means to determine change not only in the milk proteome, 22 
but also in the peptidome and in the metabolome caused by the infection. 23 
Examination of the peptidome, that is the peptides of less than 25kDa in molecular 24 
weight, demonstrated an increase in small peptides most of which were casein 25 
degradation products but also included small bioactive peptides such as mammary 26 
associated serum amyloid A3 (MSAA3).  The peptidome has also been shown to 27 
differ depending on the causative bacteria of naturally occuring mastitis. The use of a 28 
non-gel based relative quantitative proteomic methodology has revealed major 29 
changes in the protein component of milk in mastitis.  The S. uberis infection lead to 30 
increases in the concentrations of proteins such as cathelicidins, haptoglobin, 31 
MSAA3 and decreases milk content of proteins such as xanthine oxidase, 32 
butyrophilin and -1,4-galactosyltransferase. Analysis of all protein change data 33 
identified the acute phase, coagulation and complement pathways as well as proteins 34 
related to bile acid metabolism as being most modified. Examination of the small 35 
molecular weight organic molecules of milk using a metabolomic approach identified 36 
an increase in the content in milk during mastitis of bile acids such as 37 
taurochenodeoxycholic acid.  Notable changes were also found in metabolites 38 
 
 
responding to infection of the mammary gland.  Carbohydrate and nucleic acid 39 
metabolites were reduced while lipid and nitrogen containing metabolites were 40 
increased. The latter included increases in amino acids along with di and tri peptides, 41 
likely to be the result of casein degradation.  The use of proteomics and other omic 42 
technology is in its infancy in investigation of lactational parameters, but can already 43 
provide additional insight into the changes involved in disease and will have further 44 
value in physiological and nutritional investigation of lactation. 45 
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Implications  49 
The application of the advanced analytical technology of proteomics to the study of 50 
milk from dairy cows has been growing over the last few decades.  This approach 51 
allows detection and measurement of a vast number of proteins in milk and has 52 
allowed studies to be undertaken of the changes that take place in milk, especially in 53 
response to infections of the mammary gland that cause the major disease of bovine 54 
mastitis.  This has revealed major changes in the milk proteins with some protein 55 
such as haptoglobin increasing in concentration while others such as -lactalbumin 56 
decreasing in following infection.     57 
58 
 
 
Proteomics in lactation biology  59 
Proteomics which is the application of advanced technology such as nano liquid 60 
chromatography (LC) and mass spectrometry (MS) to characterise the full 61 
complement of proteins in a biological sample, has had an increasing role in 62 
investigations of animal science and veterinary medicine (Almeida et al., 2014).   This 63 
is not only to provide novel insights into the physiology and pathophysiology of farm 64 
and companion animals  but also to provide insight into questions on basic scientific 65 
questions which includes the processes involved in lactation required for maximising 66 
milk production (Bilic et al., 2018).  While still to mature into a widespread 67 
technology, proteomics and related omic approaches such as metabolomics, the 68 
analysis of all metabolites in a sample, there has been considerable progress. This is 69 
exemplified by contrasting the major texts on animal proteomic approaches 70 
separated by only seven years from 2011 (Eckersall and Whitfield, 2011) to 2018 71 
(Almeida et al., 2018) showing evidence of an active scientific community developing 72 
this new discipline for investigation of animal biology in relation to livestock 73 
production in agriculture and in the health of companion animals.  In relation to 74 
investigation of lactation, there have been reviews of application of proteomics in 75 
study of milk as a nutritious food and in its processing into cheeses (Soggiu et al., 76 
2018) as well as applications to the study of mammary gland biology in health and 77 
disease (Almeida and Eckersall, 2018).   78 
Investigation of mastitis and the changes in the proteome and the metabolome of 79 
milk is one of the major areas where these approaches have been applied and has 80 
yielded results of significant impact especially in the search for biomarkers in milk of 81 
mastitis, the major economically important  disease of dairy (Mudaliar et al., 2017). 82 
This has implications for animal welfare and also for potentially reducing the use 83 
 
 
antimicrobials for treatments that are causing concern in relation to the growth of 84 
antimicrobial resistance of the relevant pathogens.  This review will therefore focus 85 
on recent reports on the use of different approaches of using proteomic and other 86 
omic technologies to investigate this specific but important area of lactation biology in 87 
ruminants. 88 
Lactational change in mammary infection 89 
Interest in the use of proteomics in investigation of the change in milk protein in 90 
response to mastitis has evolved over time along with advances in proteomic 91 
technology.  Earlier investigations made use of 2 dimension electrophoresis (Hogarth 92 
et al., 2004) but more recently the use of liquid chromatography and mass 93 
spectrometry (LC-MS/MS) has allowed improved quantification and increased the 94 
sensitivity of detection for less abundant proteins (Soggiu et al., 2018).  These non-95 
gel based, quantitative proteomic methods are being increasingly applied to the 96 
measurement of multiple proteins in milk in either experimentally induced or naturally 97 
occurring mastitis.    98 
A study of mastitis caused by Staphylococcus aureus infection in which milk whey 99 
from cows with this bacteria were compared to milk from healthy cows and used a 100 
labelled free quantitative approach to identify differentially abundant protein in the 101 
whey (Abdelmegid et al., 2018).   In all, 90 proteins were identified, and 25 of these 102 
showed significant differences between groups.  The overriding functional activity of 103 
these proteins was that they are involved in the host defence against infection largely 104 
as part of the innate immune system. The functions the proteins fulfil included 105 
antimicrobial activity, pathogen recognition, and the acute phase response.  Within 106 
the latter group, haptoglobin (Hp) and lipopolysaccharide-binding protein (LBP) were 107 
identified, while cathelicidin-4 (CATHL4), peptidoglycan recognition protein1 108 
 
 
(PGLYRP1), lactoperoxidase (LPO), lactotransferrin (Lactoferrin) (LTF), histone 109 
proteins (histone H4 and Histone H2A), and cathepsin B (CTSB) were also proteins 110 
that were increased in S. aureus infection. Proteins involved in pathogen-recognition 111 
also included lipopolysaccharide-binding protein (LBP) as well as monocyte 112 
differentiation antigen (CD14), and chitinase-3-like protein 1 (CHI3L1). 113 
A quantitative proteomic approach has also been taken in the search for the optimal 114 
biomarker, or combination of biomarkers for bovine disease (Zoldan et al., 2017). 115 
Biomarkers found in milk for a range of diseases, including mastitis but also non 116 
mammary disease, indicated that the milk Hp concentration had the highest values 117 
among potential biomarkers for sensitivity and specificity and these discriminatory 118 
capabilities were increased in combination with the lactoferrin or secretory 119 
component, of immunoglobulin A (IgA).  It was apparent that the milk concentrations 120 
of Hp were increased by extra mammary inflammatory diseases, though the levels of 121 
milk Hp found by immunoassay were appreciably higher when mastitis was the 122 
causative disease. In a separate but relevant quantitative proteomics investigation 123 
(Altena et al., 2016), 13 milk proteins, including CD9, -glutamyl transferase, 124 
lactoferrin and CD36, were found by nanoLC-MS/MS to be more abundant in dairy 125 
cows classified as being less resistant to natural diseases, which, as well as mastitis, 126 
included lameness, retained placenta, metritis, respiratory diseases and metabolic 127 
diseases such as ketosis.  It appears that systemic, non-mammary disease does 128 
affect the milk proteome.  Whether such changes are sufficient to allow an assay in 129 
milk to be used as a diagnostic for health assessment in dairy cows will require 130 
extensive validation and careful implementation. 131 
 
 
In post discovery phases of potential biomarkers for mastitis, the use of selective 132 
reaction monitoring MS to quantify targeted specific proteins has been reported 133 
(Kusebauch et al., 2018). In this method isotope-labelled reference peptides were  134 
generated by chemical synthesis for 13 host response proteins considered to be 135 
altered in abundance in milk due to mastitis: lactoferrin, -2 macroglobulin, -1 136 
antitrypsin, Hp, serum amyloid A3, CD14, calgranulin B, calgranulin C, cathepsin C, 137 
vanin-1, galectin-1, galectin-3, and interleukin-8.  These proteins were shown to be 138 
altered by lipopolysaccharide endotoxin from gram negative Escherichia coli and also 139 
the proteoglycan from gram positive S. aureus.  However, the relative changes in 140 
abundance differed between these bacteria and if this altered host response is 141 
confirmed in future investigation this proteomic procedure could be the basis for a 142 
differential test for the gram-negative and gram-positive bacteria as the cause of the 143 
mastitis. 144 
The validation of biomarkers identified by proteomics is a key process in adoption in 145 
diagnosis.  This has been illustrated by initial identification of cathelicidin as a marker 146 
for mastitis (Addis et al., 2013). Although the initial discovery was made with a 147 
proteomic approach in ovine mammary epithelial cells following S. uberis mastitis, 148 
subsequent investigation of bovine mastitis using an immunoassay with an antibody 149 
to synthetic pan-cathelicidin peptides has shown that the cathelicidin in milk is highly 150 
correlated to somatic cell count the currently favoured test for mastitis, in over 500 151 
milk samples used in validation studies. Cathelicidin has also been identified as a 152 
biomarker in Streptococcus agalactiae caused cases of mastitis, although by use of 153 
the classic proteomic method of 2 dimension electrophoresis along with MS 154 
(Pongthaisong et al., 2016). 155 
  156 
 
 
Integrated omics in lactation 157 
Proteomics is one of a number of ‘omic’ sciences which when combined provide the 158 
tools for a systems biology research approach.  In mammary gland biology there 159 
have been many genomic and transcriptomic investigations (Mudaliar et al., 2017) 160 
but the integration of other technology such as proteomics and metabolomics has 161 
been rare. However, a combined investigation of Streptococcus uberis mastitis in 162 
which proteomics, metabolomics and peptidomics has been undertaken (Thomas et 163 
al., 2016a; Thomas et al., 2016b; Mudaliar et al., 2016)   . These technologies were 164 
applied to determine the changes taking place in the metabolites, peptides and 165 
proteins following infection of mammary glands with of S. uberis (Tassi et al. 2013) 166 
and in relation to the resultant inflammation and final resolution. Overall this 167 
‘Mastitomics’ investigation analysed small molecules with a mass less than 1500 Da 168 
(metabolomics), peptides and polypeptide fragments in the range of 380–6000 Da 169 
(peptidomics) and proteins with masses ranging up to 3 MDa (proteomics). The omic 170 
results were compared to mastitis outcome based on clinical signs, SCC and 171 
bacterial count and acute phase protein concentration in milk at six time points post-172 
challenge. Omic analysis was performed by capillary electrophoresis-mass 173 
spectrometry (CE-MS), LC-MS/MS and LC-MS for peptidomic, proteomic and 174 
targeted metabolomic data respectively and quantitative results of relative 175 
abundance to control samples were generated.  176 
Peptidomics revealed 460 peptides, of which 77 peptides were able to classify pre- 177 
and post-infection time points (Thomas et al., 2016b).  Most peptides were 178 
degradation products of casein proteolysis. Other small peptides identified were 179 
serum amyloid A and glycosylation-dependent cell adhesion molecule 1 (GDCAM).  180 
Peptidomics revealed a reduction in the caseins, first at 36-h post-challenge and 181 
 
 
continuing even after the elimination of infection, and the alteration in abundance 182 
were likely to be caused by host or bacterial proteases.  A previous peptidomic 183 
investigation of natural clinical mastitis (Mansor et al., 2013) using the same 184 
approach demonstrated the possibility of combining peptide analysed into biomarker 185 
panel for diagnosis of mastitis and also for differential diagnosis between gram 186 
positive and gram negative bacteria causing the infection.  Further validation of such 187 
an approach will be needed before milk peptide panels could be used for disease 188 
diagnosis. 189 
Mastitomics proteomics quantified 570 bovine proteins that changed in abundance 190 
over the course of the infection (Mudaliar et al., 2016). Of particular interest was that 191 
the proteomics analysis showed more than an 1000x increase in antimicrobial 192 
proteins such as peptidoglycan recognition protein 1 and the cathelicidins between 193 
36 and 81 h post-challenge.  Acute phase proteins Hp, M-SAA3 and CRP, showed 194 
increased abundance by LC-MS/MS, with results validated by immunoassay, which 195 
showed similar patterns of their change in abundance. Thus the acute phase proteins 196 
in milk started increasing by 100x at 30-hour post-challenge and reached a peak at 197 
around 57 hour post challenge.  Interestingly, CRP does have a major acute phase 198 
reaction in bovine milk during mastitis (Thomas et al., 2016b) with undetectable 199 
levels being found in milk from a healthy mammary gland.  In contrast, in cattle CRP 200 
is present in serum from healthy animals and at best is a mild to moderate acute 201 
phase protein, rising only 3 fold during infection (Lee et al., 2003) and has even been 202 
reported as a negative acute phase response (Schroedl et al., 2014).  203 
Metabolomics analysis putatively identified 690 metabolites with a particularly striking 204 
increase in the concentration of bile acids following infection (Thomas et al., 2016a). 205 
The bile acids that showed elevated abundance included glycocholate 206 
 
 
(C26H43NO6), taurocholic acid (C26H45NO7S), taurochenodeoxycholic acid 207 
(C26H45NO6S), glycodeoxycholate (C26H43NO5) and cholate (C24H40O5). There 208 
was also a general increase in nitrogen containing metabolites, especially of free 209 
amino acid and di-tri-peptides, likely to be from casein degradation and also an 210 
increase in lipid metabolites.  Carbohydrates and nucleic acids were in general 211 
decreased in milk by mastitis.  The use of metabolomics to analyse milk during 212 
mastitis and provide potential biomarkers for the disease has also been reported 213 
(Dervishi et al 2016), who concluded that the amino acids, valine, serine, tyrosine 214 
and phenylalanine were predictive for subacute mastitis, even when estimated by 215 
metabolomics 4 or 8 weeks prior to calving.   216 
Integrating the analysis of the omics data particularly highlighted the up-regulation of 217 
bile acids in proteomic as well as metabolomic outcomes as pathways identified as 218 
upregulated by proteomics included liver X receptor (LXR), retinoid X receptor (LXR) 219 
and Farnesoid X receptor (FXR) activation pathways which are related to bile acid 220 
metabolism.  The acute phase response signalling pathway was also shown to be the 221 
most up regulated by mastitis.  An overview of the integrated analysis showed that 222 
while the bacterial count reached a maximum at 36–42 h post challenge, most of the 223 
host responses by proteomics or metabolomics did not reach a maximum until 57 or 224 
81 h post challenge. The combination of omic approaches provided a mass of data 225 
for bioinformatic investigation and showed the potential for an integrative approach of 226 
advanced technology to give as complete a picture of the mammary gland’s 227 
response to mastitis as is possible at present.  228 
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